Effect of Hyperbaric Oxygen Therapy(HBOT) on Patients With Sudden Sensorineural Hearing Loss(SSNHL) and Coagulation Function
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorSun Yuting
About this trial
The objective of this observational study was to understand the effect of HBO on patients with SSNHL and its association with coagulation function and prognosis.
The main question it aims to answer is whether HBO therapy can improve outcomes and coagulation function in patients with SSNHL.
The prognosis of SSNHL patients receiving HBO and SSNHL patients not receiving HBO were compared
Eligibility criteria
Qualifiers
Meet the diagnostic criteria for sudden deafness in the American Academy of Otolaryngology Head and Neck Surgery 2019 Clinical Practice Guidelines for Sudden Deafness;
Aged 18-75 years old;
Patients with unilateral sudden deafness for the first time, and the onset time is less than 2 weeks.
Disqualifiers
Patients with other ear diseases, such as auditory trauma, barotrauma, retrocochlear disease, bilateral hearing loss, history of chronic otitis media in the same ear, and history of surgery in the same ear;
Patients with serious primary diseases such as heart, liver, kidney dysfunction and hematopoietic system diseases;
Pregnant and nursing patients;
Accompanied by serious mental illness;
Trial design
Treatments tested in this trial
- Hyperbaric oxygen treatment
Treatment groups
No treatment groups listed
Sponsors and collaborators
Sun Yuting
Lead sponsor
Shanghai University of Traditional Chinese Medicine
Sponsor institution
Source ClinicalTrials.gov